Treatment
-
New Frontiers in COVID-19 and Autoimmunity
Written by: Chumeng Wang Edited by: Esther Melamed Since the beginning of the COVID-19 pandemic, researchers and clinicians have sought to determine predispositions that may put individuals at higher risk for severe disease. As the virus spread and information became available about typical recovery times, more questions arose as some patients reported symptoms of Long COVID,…
-
The Cautionary Tale of Ivermectin: Consequences of Flawed Research
Written by: Akshara Ramasamy Edited by: Esther Melamed The global desire for COVID-19 preventive and therapeutic treatment options has resulted in a demand for both randomized clinical studies and systematic analysis of such studies. However, this high demand for information has also led to data presentation/publications of varying quality via publication channels that may or may…
-
ACTIV-4 Preliminary Results Demonstrate Efficacy of Blood Thinners in Severe COVID-19 Patients
Written by: Cole Maguire Edited by: Esther Melamed Throughout the course of the COVID-19 pandemic, it has been recognized that a number of pressing secondary pathologies often develop in patients with severe COVID-19 disease. One of these secondary pathologies is COVID Associated Coagulopathy (CAC), which results in an over-abundance of clotting in the body and can…
-
Acute brain dysfunction in COVID-19 intensive care patients can be mitigated with care and contact
Written by: Blaine Caslin Edited by: Esther Melamed While the vaccine rollout is bringing a glimmer of hope for the pandemic, many people are still getting hospitalized for COVID-19 and needing to be treated in the intensive care unit (ICU). Doctors and scientists are continuing to develop new clinical guidelines and models of care to…
-
A New Year of COVID
Written by: Sam Bazzi Edited by: Esther Melamed At any other time, celebrating the advent of January 1st is a ritual that allows us to reflect on the past 12 months, find hope for the upcoming year, and make resolutions to improve our lives. Unfortunately, SARS-CoV-2 did not get the memo about the new year…